Whistleblower Policy

BioInnovation Institute is covered by The Novo Nordisk Foundation and Novo Holdings A/S’ whistleblower policy and scheme. The purpose of the policy and scheme is to promote transparency and increase accountability for the behavior of BII and its collaborators by allowing people to report potential breaches of BII’s code of conduct anonymously.